Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

NCT00755885 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: abiraterone acetate
OTHER: laboratory biomarker analysis
OTHER: pharmacogenomic studies

Sponsor

Cancer Research UK